Some said Nike was on the slip. Some said thee influence of the Swoosh was on the wane. But one quick realignment, and a ...

Silo Pharma Inc. (Nasdaq: SILO) is a developmental stage biopharmaceutical company focused on addressing underserved conditions, including stress-induced psychiatric disorders, chronic pain, and ...

Silo Pharma and Hoth Therapeutics announced a joint venture to develop a VA-co-developed obesity treatment utilizing GDNF technology.

The partnership aims to leverage the VA’s clinical infrastructure alongside Hoth’s regulatory expertise and Silo’s translational capabilities.

Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market ...

NEW YORK - Hoth Therapeutics, Inc. (NASDAQ:HOTH), a biotech firm with strong financial health showing more cash than debt on its balance sheet, and Silo Pharma, Inc. (NASDAQ:SILO) announced Wednesday ...

Such statements involve known and unknown risks, uncertainties, and other factors that could cause the actual results of Silo Pharma, Inc. ("Silo" or "the Company") to differ materially from the ...

Technology Co-Developed by the U.S. Department of Veterans Affairs and Emory University NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a ...

NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and ...

Looking for something new to stream this weekend? JustWatch has released its latest rankings of the most-watched Apple TV+ titles in June.